These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23385001)

  • 1. Research resources for tuberculosis at the National Institute of Allergy and Infectious Diseases.
    NIH, DMID TB program
    Tuberculosis (Edinb); 2013 Jan; 93(1):6-11. PubMed ID: 23385001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance.
    Peters NK; Dixon DM; Holland SM; Fauci AS
    J Infect Dis; 2008 Apr; 197(8):1087-93. PubMed ID: 18419527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biomedical research in global tuberculosis control: gaps and challenges: A perspective from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health.
    Sizemore CF; Schleif AC; Bernstein JB; Heilman CA
    Emerg Microbes Infect; 2012 Jul; 1(7):e9. PubMed ID: 26038420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AIDS research agenda at the National Institutes of Health.
    Minor JR; Hamburg MA
    Am J Hosp Pharm; 1991 Dec; 48(12):2662-6. PubMed ID: 1667566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research.
    Fauci AS;
    J Infect Dis; 2008 Jun; 197(11):1493-8. PubMed ID: 18426366
    [No Abstract]   [Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development.
    Nuermberger E; Sizemore C; Romero K; Hanna D
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1177-82. PubMed ID: 26824941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).
    Grabowski J
    Addiction; 2010 Dec; 105(12):2044-9. PubMed ID: 20712817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Institute of Allergy and Infectious Diseases names key new components of HIV/AIDS research networks.
    J Investig Med; 2007 May; 55(4):154. PubMed ID: 17651666
    [No Abstract]   [Full Text] [Related]  

  • 11. Informatics resources for tuberculosis--towards drug discovery.
    Sundaramurthi JC; Brindha S; Reddy TB; Hanna LE
    Tuberculosis (Edinb); 2012 Mar; 92(2):133-8. PubMed ID: 21943870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TBCAP; tuberculosis annotation project.
    Brennan PJ; Brosch R; Birren B; Sobral B
    Tuberculosis (Edinb); 2013 Jan; 93(1):1-5. PubMed ID: 23332402
    [No Abstract]   [Full Text] [Related]  

  • 13. The tuberculosis epidemic. Scientific challenges and opportunities.
    Ginsberg AM
    Public Health Rep; 1998; 113(2):128-36. PubMed ID: 9719813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease.
    Fauci AS
    JAMA; 2018 Oct; 320(13):1315-1316. PubMed ID: 30267054
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of programs to support new investigators at the National Institute of Allergy and Infectious Diseases: Striking a balance with funding for established investigators.
    Zane AC; Onken J; Parker MB; Ghosh D
    Eval Program Plann; 2023 Jun; 98():102218. PubMed ID: 36963190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccine research: the way forward.
    Fauci AS; Johnston MI; Dieffenbach CW; Burton DR; Hammer SM; Hoxie JA; Martin M; Overbaugh J; Watkins DI; Mahmoud A; Greene WC
    Science; 2008 Jul; 321(5888):530-2. PubMed ID: 18653883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIAID meeting report: improving malaria vaccine strategies through the application of immunological principles.
    Mo AX; Augustine AD
    Vaccine; 2014 Feb; 32(10):1132-8. PubMed ID: 24060568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIAID/NIH radiation/nuclear medical countermeasures product research and development program.
    Hafer N; Cassatt D; Dicarlo A; Ramakrishnan N; Kaminski J; Norman MK; Maidment B; Hatchett R
    Health Phys; 2010 Jun; 98(6):903-5. PubMed ID: 20445403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic function and the immune response to microbial or viral infection.
    Miller LR
    Lymphat Res Biol; 2013 Sep; 11(3):116. PubMed ID: 24024575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    Int J Tuberc Lung Dis; 2009 May; 13(5):558-68. PubMed ID: 19383187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.